Skip to content

Drug interactions

Diltiazem + Tofacitinib

Severity: Moderate

Diltiazem and Tofacitinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Diltiazem is a moderate CYP3A4 inhibitor and can increase tofacitinib exposure. The increase is generally modest but may add to infection and cytopenia risk.

What this interaction means in plain words

Diltiazem and Tofacitinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Diltiazem belongs to Cardiovascular; Tofacitinib belongs to Musculoskeletal.

Evidence level: Moderate

Why it happens

Inhibition of CYP3A4 by diltiazem decreases tofacitinib clearance.

What to do

No routine dose change is needed for a moderate CYP3A4 inhibitor alone; monitor for adverse effects and reduce the tofacitinib dose if a potent CYP2C19 inhibitor is also used.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Diltiazem and Tofacitinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Diltiazem with Tofacitinib?

MediHelp rates the interaction as moderate. Diltiazem and Tofacitinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Diltiazem is a moderate CYP3A4 inhibitor and can increase tofacitinib exposure. The increase is generally modest but may add to infection and cytopenia risk.

How serious is the interaction between Diltiazem and Tofacitinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine dose change is needed for a moderate CYP3A4 inhibitor alone; monitor for adverse effects and reduce the tofacitinib dose if a potent CYP2C19 inhibitor is also used.

What other medicines interact with Tofacitinib?

MediHelp also lists interactions of Tofacitinib with, for example, Baricitinib, Cladribine, Upadacitinib. The full list is on the Tofacitinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in